Methyl Alcohol

Methyl Alcohol

SCHEMBL295188

CC1CCCC(C)C1.CO

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
TRPA1 O75762 2/20 0.35
TRPM8 Q7Z2W7 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10306742 0.93
SCHEMBL599394 0.93
SCHEMBL599393 0.93
SCHEMBL22878856 0.93
SCHEMBL601777 0.93
SCHEMBL132918 0.93
SCHEMBL28964143 0.89
Fluoride SCHEMBL28167670 0.89
Ammonia Solution, Strong SCHEMBL8931560 0.89
SCHEMBL28091640 0.89 CYP2C9 (0.37) CYP2C9TSHRCYP2C19TDP1TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8603962-B2 Methods for treating fabric in a dryer with a composition comprising silicic acid esters THE DIAL CORPORATION (US) 2013-12-10 US claimed
EP-2142631-B1 METHODS FOR TREATING FABRIC IN A DRYER DIAL CORP (US) 2012-03-14 EP claimed
EP-2142631-A1 METHODS FOR TREATING FABRIC IN A DRYER The Dial Company (US) 2010-01-13 EP claimed
WO-2008134212-A1 METHODS FOR TREATING FABRIC IN A DRYER THE DIAL COMPANY (US) 2008-11-06 WO claimed
EP-1056739-B1 NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE PROCTER & GAMBLE (US) 2003-05-02 EP claimed
US-6500797-B1 Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones THE PROCTER & GAMBLE COMPANY 2002-12-31 US claimed
US-12624216-B2 Method for the production of free-flowing granules OMYA INTERNATIONAL AG (CH) 2026-05-12 US disclosed
EP-4142675-B1 GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS EXCIPIENT OMYA INT AG (CH) 2026-03-25 EP disclosed
EP-4143136-B1 METHOD FOR THE PRODUCTION OF FREE-FLOWING GRANULES OMYA INT AG (CH) 2025-09-10 EP disclosed
US-20240327232-A1 METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL OMYA INTERNATIONAL AG (CH) 2024-10-03 US disclosed
EP-4396133-A1 METHOD FOR THE PRODUCTION OF GRANULES COMPRISING A MAGNESIUM ION-COMPRISING MATERIAL Omya International AG (CH) 2024-07-10 EP disclosed
EP-4146743-B1 COATINGS COMPRISING ANTIMICROBIAL ACTIVE INGREDIENTS FOR FOOD PACKAGING OMYA INT AG (CH) 2024-07-03 EP disclosed
CN-117794861-A Process for producing pellets comprising magnesium ion containing material OMYA国际股份公司 2024-03-29 CN disclosed
WO-1998007455-A1 ODOR CONTROL COMPOSITIONS COMPRISING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007813-A2 LAUNDRY DETERGENT COMPOSITIONS COMPRISING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007812-A2 AUTOMATIC DISHWASHING DETERGENTS COMPRISING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007810-A2 HAND-WASH LAUNDRY DETERGENT COMPOSITIONS COMPRISING BETA-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007407-A1 FRAGRANCE DELIVERY SYSTEMS FOR PERSONAL CARE ARTICLES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998007809-A2 HARD SURFACE CLEANERS COMPRISING β-KETOESTER PRO-FRAGRANCES THE PROCTER & GAMBLE COMPANY (US) 1998-02-26 WO disclosed
WO-1998006803-A1 RINSE ADDED FABRIC SOFTENING COMPOSITIONS AND METHOD OF USE FOR THE DELIVERY OF FRAGRANCE PRECURSORS THE PROCTER & GAMBLE COMPANY (US) 1998-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624216-B2 Method for the production of free-flowing granules TMCO1, ORAI1, CACNA1G CYP2C9 1121/4885TSHR 1070/4885CYP2C19 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.